Literature DB >> 18390458

Adherence to oral endocrine therapy for breast cancer: a nursing perspective.

Christine Miaskowski1, Lillie Shockney, Rowan T Chlebowski.   

Abstract

Many factors contribute to the success or failure of adjuvant therapy, but perhaps one of the most critical is treatment adherence. Patients do not adhere to prescribed therapy for a variety of reasons, and each one should be uncovered and addressed or managed accordingly to maintain therapeutic levels and give patients the best chance for positive outcomes. Nurses are well positioned to play a central role in promoting adherence by ensuring that patients understand the need for treatment and by identifying any underlying causes of nonadherence to therapy. When the issues are identified and addressed effectively, patients' chances for successful clinical outcomes are greatly improved. This article summarizes the issues surrounding adherence, paying specific attention to adjuvant endocrine therapy for breast cancer, and outlines strategies to reduce nonadherence that nurses can incorporate into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390458     DOI: 10.1188/08.CJON.213-221

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  19 in total

Review 1.  Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.

Authors:  Megan C Roberts; Stephanie B Wheeler; Katherine Reeder-Hayes
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

2.  Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.

Authors:  Gretchen Kimmick; Sara N Edmond; Hayden B Bosworth; Jeffrey Peppercorn; Paul K Marcom; Kimberly Blackwell; Francis J Keefe; Rebecca A Shelby
Journal:  Breast       Date:  2015-07-16       Impact factor: 4.380

3.  Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.

Authors:  Renée Simon; Jean Latreille; Claire Matte; Pierre Desjardins; Eric Bergeron
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

4.  Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial.

Authors:  C Riese; B Weiß; U Borges; A Beylich; R Dengler; K Hermes-Moll; M Welslau; W Baumann
Journal:  Support Care Cancer       Date:  2017-06-09       Impact factor: 3.603

Review 5.  Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.

Authors:  Caitlin C Murphy; L Kay Bartholomew; Melissa Y Carpentier; Shirley M Bluethmann; Sally W Vernon
Journal:  Breast Cancer Res Treat       Date:  2012-06-12       Impact factor: 4.872

6.  Patient adherence to aromatase inhibitor treatment in the adjuvant setting.

Authors:  S Verma; Y Madarnas; S Sehdev; G Martin; J Bajcar
Journal:  Curr Oncol       Date:  2011-05       Impact factor: 3.677

Review 7.  Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.

Authors:  Lorena Rocha Ayres; André de Oliveira Baldoni; Anna Paula de Sá Borges; Leonardo Régis Leira Pereira
Journal:  Int J Clin Pharm       Date:  2013-08-11

8.  The 2009-2013 research agenda for oncology nursing.

Authors:  Ann M Berger; Barbara Cochrane; Sandra A Mitchell
Journal:  Oncol Nurs Forum       Date:  2009-09       Impact factor: 2.172

Review 9.  Breast cancer medications and vision: effects of treatments for early-stage disease.

Authors:  Alvin Eisner; Shiuh-Wen Luoh
Journal:  Curr Eye Res       Date:  2011-08-05       Impact factor: 2.424

10.  Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study.

Authors:  Zerko Wako; Daniel Mengistu; Negalign Getahun Dinegde; Tseganesh Asefa; Mulugeta Wassie
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.